One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Catheterization and Cardiovascular Interventions

7 Gennaio Gen 2020 6 months ago
  • De Martini S, Fabbiocchi F, Bartorelli A,

The ULISSE registry evaluated the real-world performance of the Ultimaster® biodegradable polymer sirolimus-eluting stent (BP-SES) in a multicenter-independent cohort of patients undergoing percutaneous coronary intervention, including a large proportion of diabetes mellitus (DM) patients.

Reference

Beneduce A, Ferrante G, Ielasi A, Pivato CA, Chiarito M, Cappelletti A, Baldetti L, Magni V, Prati E, Falcone S, Pierri A, De Martini S, Montorfano M, Parisi R, Rutigliano D, Locuratolo N, Anzuini A, Tespili M, Margonato A, Benassi A, Briguori C, Reimers B, Fabbiocchi F, Bartorelli A, Colombo A, Godino C. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry). Catheter Cardiovasc Interv 2020 Jan 6. doi: 10.1002/ccd.28694.

Go to PubMed